12-Month Lobbying Summary - Consultant

• Subject matter details in previous versions

  Details Regarding the Identified Subject Matter

  Subject matters	Details	Categories
  Subject matters were not required to be associated with subject matter details when this content was submitted	Discuss policies around anti-microbial resistance, infection prevention and medication errors	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Federal budget with respect to public sector investments in long-term care and home care.	Legislative Proposal, Bill or Resolution
  Subject matters were not required to be associated with subject matter details when this content was submitted	Federal budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and device innovation and adoption, support and delivery new models of care, equitable healthcare access, and women’s health.	Legislative Proposal, Bill or Resolution
  Subject matters were not required to be associated with subject matter details when this content was submitted	Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Federal initiatives with respect to the Canadian Life Sciences strategy and intergovernmental policy, funding, legislative, and guideline changes.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Federal life sciences strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and diagnostic testing.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes.	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Federal science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	North American Free Trade Agreement (NAFTA), with respect to provisions relating to medical devices and technologies	Policies or Program
  Subject matters were not required to be associated with subject matter details when this content was submitted	Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies	Regulation

  Subject matters in previous versions

  • Economic Development
  • Education
  • Government Procurement
  • Health
  • Industry
  • Research and Development
  • Science and Technology
  • Taxation and Finance

Government Institutions

• Canadian Institutes of Health Research (CIHR)
• Health Canada (HC)
• House of Commons
• Innovation, Science and Economic Development Canada (ISED)
• Invest in Canada Hub
• Public Health Agency of Canada (PHAC)
• Public Services and Procurement Canada (PSPC)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

• Oral communication
• Written communication
• Arrange one or more meetings

Danielle Flieler, Consultant (Business address and contact information)